Coccinia grandis
Coccinia grandis · Accepted scientific name
Scientific literature: Very Sparse (8 studies) · ★☆☆☆☆
Coccinia grandis is a versatile plant whose medicinal potential is derived from its leaves, fruit, and roots. Various preparations, such as aqueous extracts and the ethanol extract of Coccinia grandis leaves (EECGL), are utilized to harness its bioactive properties. The plant contains essential components including copper, manganese, polyprenol, and pectin, which contribute to its diverse therapeutic activities. Research highlights its significant roles as an antioxidant, antidiabetic agent, acidulant, and aldose-reductase inhibitor. Consequently, it shows great promise in managing conditions like diabetes mellitus, oxidative stress, and apoptosis by regulating blood glucose levels.
- Synonyms
- Momordica Bicolor · Momordica Covel · 25 more
- Common names
- Not available
- Family
- Cucurbitaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Fruit
Classification
Common Names
Coccinia grandis is a versatile plant recognized by a wide variety of regional and international names. In English-speaking regions, it is most frequently referred to as the ivy gourd. This climbing vine is also known as Courge écarlate in certain contexts, reflecting its distinct appearance. Depending on the local culture, you might hear it called Kemarungan or Papasan. Additionally, the name Scharlachranke is used to identify this species in other parts of the world.
Sources: Catalogue of Life (COL)
Synonyms
Coccinia grandis is a plant recognized by a variety of scientific synonyms throughout botanical history. It has been formally identified under several different names, including the designation Bryonia acerifolia. Researchers have also cataloged the species as Bryonia alceifolia and Bryonia barbata in various texts. Additionally, the plant is linked to the names Bryonia grandis and Bryonia moimoi. These overlapping classifications reflect the complex taxonomic journey used to define this specific species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Coccinia grandis belongs to the vast kingdom Plantae, representing the diverse life found within the plant world. Within this kingdom, it is classified under the class Equisetopsida, showcasing its fundamental botanical structure. The plant is further categorized into the order Cucurbitales, which helps scientists understand its evolutionary lineage. It specifically resides within the genus Coccinia, a group defined by unique shared characteristics. Finally, its placement in the family Cucurbitaceae connects it to a well-known group of climbing vines and gourds.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cucurbitales |
| Family | Cucurbitaceae |
| Genus | Coccinia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Coccinia grandis is widely distributed across several distinct regions within the African continent. In East Tropical Africa, the plant can be found thriving in the landscapes of Kenya, Tanzania, and Uganda. Its presence also extends into Northeast Tropical Africa, where it inhabits specific areas of Chad. Additionally, the species is documented growing within the borders of Djibouti. This broad range highlights the plant's ability to adapt to various environments across these diverse African territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Coccinia grandis is a vigorous herb characterized by its obligatory climbing habit. As it ascends, this plant can reach a significant height of up to 13 meters. In certain optimal conditions, its growth may even extend to a maximum of approximately 14.33 meters. This climbing nature allows it to effectively navigate and dominate its surrounding environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Coccinia grandis is a versatile medicinal plant that demonstrates a wide range of significant therapeutic activities. Research indicates that the plant possesses potent antioxidant properties, which can be further enhanced through advanced technologies like alginate nanoparticle encapsulation. Its traditional use by indigenous communities highlights its effectiveness as an antidiabetic agent for managing glucose levels. Additionally, the plant exhibits strong antimicrobial and antifungal activities, making it a promising candidate for controlling various pathogens. Collectively, these diverse biological functions underscore the potential of Coccinia grandis in developing new pharmaceutical and phytotherapeutic interventions.
Compounds
Coccinia grandis is a plant of significant medicinal interest due to its diverse chemical composition. Trace element analysis reveals that this species contains essential metal constituents, specifically copper and manganese. Beyond these minerals, the plant serves as a source of bioactive compounds such as polyprenol, which has demonstrated potent antidyslipidemic effects. Additionally, the fruit contains pectin, a component known for its ability to induce hypoglycaemic actions. Together, these various elements highlight the complex pharmacological potential of the species.
Conditions
Coccinia grandis treats diabetes mellitus through its proven antidiabetic and antihyperglycemic properties. This medicinal plant treats blood glucose by improving glucose tolerance and lowering fasting blood sugar levels. Furthermore, Coccinia grandis treats oxidative stress by acting as a natural antioxidant that regulates redox homeostasis and reduces reactive oxygen species. It also treats apoptosis by inhibiting pro-apoptotic mediators and signaling pathways like caspase 3 and 9. Ultimately, Coccinia grandis treats diabetes by ameliorating metabolic disturbances and regenerating pancreatic β-cells.
Preparations
Coccinia grandis is prepared as leaf extract to evaluate its antioxidant properties and ability to accelerate in vitro wound healing. This medicinal plant is also processed as an aqueous extract, which can be encapsulated into alginate nanoparticles to enhance its antioxidant activity. Researchers have utilized the ethanol extract of Coccinia grandis leaves (EECGL) to demonstrate significant hepato-protective and cardio-protective efficacy against MSG-induced inflammation and apoptosis. Additionally, the ethanolic crude extract of the plant has been investigated for its phytochemical and antihyperglycemic activities. Finally, the plant is prepared as a general extract to probe its potential immunomodulatory effects on various signaling pathways in human monocytic cells.
Parts used
Coccinia grandis is a medicinal plant that offers various therapeutic benefits through its different anatomical parts. Research indicates that the leaves of the plant possess significant antioxidant properties that can accelerate wound healing and protect skin cells from oxidative stress. Additionally, ethanol extracts derived from the leaves have shown potential in ameliorating systemic damage and metabolic disturbances related to fatty liver disease. The fruit of the plant is also highly valuable, as the pectin isolated from it has demonstrated significant hypoglycaemic actions in reducing blood glucose levels. Furthermore, studies on related species suggest that extracts from the roots can contribute to these essential medicinal effects.